Navana Pharmaceuticals PLC (DSE:NAVANAPHAR)
Bangladesh · Delayed Price · Currency is BDT 64.00
-0.60 (-0.93%)
At close: Sep 24, 2026
Navana Pharmaceuticals Market Cap
Navana Pharmaceuticals has a market cap or net worth of 6.87 billion as of September 25, 2026. Its market cap has increased by 12.68% in one year.
Market Cap
6.87B
Enterprise Value
10.52B
Revenue
10.57B
Ranking
n/a
PE Ratio
11.42
Stock Price
64.00
ChartMarket Cap Chart
Since October 18, 2022, Navana Pharmaceuticals's market cap has increased from 2.84B to 6.87B, an increase of 142.42%. That is a compound annual growth rate of 25.22%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 24, 2026 | 6.87B | 23.31% |
| Dec 30, 2025 | 5.57B | 6.79% |
| Dec 30, 2024 | 5.22B | -42.42% |
| Dec 28, 2023 | 9.07B | 7.79% |
| Dec 29, 2022 | 8.41B | 196.59% |
| Oct 18, 2022 | 2.84B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Beacon Pharmaceuticals | 23.40B |
| The ACME Laboratories | 16.57B |
| Asiatic Laboratories | 12.90B |
| The IBN SINA Pharmaceutical Industry | 9.85B |
| Orion Pharma | 5.85B |
| Techno Drugs | 5.19B |
| Ambee Pharmaceuticals | 1.82B |
| Silco Pharmaceuticals | 1.81B |